(Q38206277)

31 August 2017

Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review (English)

1 reference

31 August 2017

0 references

cervix uterine cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

C Richard Schlegel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Guixang Wang

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jerome L Belinson

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

1 March 2014

1 reference

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

647-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Pathology and epidemiology of HPV infection in females

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Carcinoma in situ of the cervix and its malignant potential. A lesson from New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

The costs of reducing loss to follow-up in South African cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Assessing participation of women in a cervical cancer screening program in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Factors that affect the quality of cytologic cervical cancer screening along the Mexico–United States border

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

HPV screening for cervical cancer in rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Human papillomavirus testing in the prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Secondary screening after primary self-sampling for human papillomavirus from SHENCCAST II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

The genus Artemisia: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Biologically active substances from the genus Artemisia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

An Over Four Millennium Story Behind Qinghaosu (Artemisinin)-A Fantastic Antimalarial Drug from a Traditional Chinese Herb

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Artesunate derived from traditional Chinese medicine induces DNA damage and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Molecular modes of action of artesunate in tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Anticancer activities of artemisinin and its bioactive derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Factors determining sensitivity or resistance of tumor cell lines towards artesunate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.13.228

21 January 2018

Identifiers

DOI

10.2217/FON.13.228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24754594%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference